Cocrystal Pharma COCP
Cocrystal Pharma: quarterly report for the quarter ended Mar 31, 2020
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0001493152-20-008508
- Document
- 10-Q
- Exhibit 10.7
- Material contract
Not explained yet; the original is on EDGAR.
Similar companies
Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- Kiora Pharmaceuticals KPRX public float $10M, Jun 30, 2025
- Cellectar Biosciences CLRB public float $13M, Jun 30, 2025
- Scienture Holdings SCNX public float $10M, Jun 30, 2025
- Traws Pharma ONTX public float $10M, Jun 30, 2025
- Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025
